Offering buprenorphine medication to people with opioid use disorder in jail may reduce rearrest and reconviction
The study was conducted in two rural Massachusetts jails.
Stay updated with breaking news from Peter Friedmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study was conducted in two rural Massachusetts jails.
AMHERST — After researching two local jails, Baystate Medical Center and the University of Massachusetts Amherst researchers have published a new study that found a substantial reduction in recidivism when a jail offers those with opioid use disorder...
AMHERST — After researching two local jails, Baystate Medical Center and University of Massachusetts Amherst researchers have published a new study that found a substantial reduction in recidivism when a jail offers those with opioid use disorder the...
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved
A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication.